Revvity, Inc. — Earnings Quality Grade F
RVTY · Healthcare
Major red flags
Screening Summary
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO increased by 11 days
AR growth 17.8% exceeds revenue growth 3.7%
Revenue 3.7%, CFFO -7.2%. Cash follows revenue
Expense Quality
Inventory 3.2% vs COGS 6.1%. Normal
CapEx growth -15.1% vs revenue 3.7%. Normal
SG&A/Gross Profit = 63.4%. Normal
Gross margin 54.8%, change -1.0pp. Stable
Cash Flow Quality
CFFO/NI = 2.42. Profits backed by cash
FCF $0.5B, FCF/NI = 2.11
Accruals ratio = -2.8%. Low accruals
Cash $0.9B covers only 27% of debt $3.4B
Balance Sheet Health
Goodwill+Intangibles $9.0B = 124% of equity. Over 50%
Debt/EBITDA = 4.4x (>4x). Financial stress
Other assets 12.2% vs revenue 3.7%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -2% YoY. Normal
Manipulation Score
M-Score = -2.45 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-09